Listing criteria for heart transplantation in the Netherlands

N de Jonge1, K Damman2, F Z Ramjankhan3

  • 1Department of Cardiology, University Medical Centre Utrecht, Utrecht, The Netherlands. n.dejonge@umcutrecht.nl.

Insights

Updated heart transplant listing criteria prioritize patients benefiting most from scarce donor organs. This ensures optimal life expectancy and quality of life for end-stage heart disease patients.

Area of Science:

  • Cardiology
  • Transplantation Medicine

Background:

  • Donor heart shortage necessitates careful patient selection for heart transplantation.
  • End-stage heart disease management requires advanced therapeutic strategies.

Purpose of the Study:

  • To present updated listing criteria for heart transplantation in the Netherlands.
  • To guide the selection of patients who will gain the greatest benefit from heart transplantation.

Main Methods:

  • Review of current practices and patient outcomes.
  • Assessment of end-stage heart disease severity through cardiopulmonary stress testing, prognostic stratification, and invasive hemodynamic measurements.
  • Consideration of optimal medical therapy, including implantable cardioverter-defibrillator (ICD) and cardiac resynchronization therapy with defibrillation (CRT-D).

Main Results:

  • Updated criteria focus on maximizing life expectancy and quality of life from scarce donor hearts.
  • Timely referral to tertiary centers is crucial for optimal patient outcomes.
  • Chronic mechanical circulatory support is increasingly utilized as a bridge to transplantation and for advanced heart failure.

Conclusions:

  • Revised listing criteria aim to optimize the allocation of donor hearts.
  • Mechanical circulatory support offers a vital alternative and bridge for patients awaiting heart transplantation.
  • Integrated management of advanced heart failure involves transplantation and mechanical support.